Tacrolimus Capsules I.P. 0.25 mg`````

Tacrolimus Capsules I.P. 0.25 mg
TACRENOLIME 0.25  is an immunosuppressive medication used to reduce the activity of the immune system. TACRENOLIME 0.25 is commonly prescribed to prevent organ rejection in people who have undergone organ transplantation, such as kidney, liver, or heart transplants. The formulation you mentioned, TACRENOLIME 0.25 ,

TACRENOLIME 0.25  belongs to a class of drugs known as calcineurin inhibitors. TACRENOLIME 0.25  works by suppressing the activity of T lymphocytes, a type of white blood cell involved in the immune response.
Organ Transplantation:

TACRENOLIME 0.25 is commonly used as part of the immunosuppressive regimen following organ transplantation.TACRENOLIME 0.25 helps prevent the recipient's immune system from attacking and rejecting the transplanted organ.

TACRENOLIME 0.25 is typically taken orally in the form of capsules.TACRENOLIME 0.25  is important to take the medication consistently as prescribed by the healthcare provider.
Monitoring:

Regular monitoring of blood levels ofTACRENOLIME 0.25  is essential to ensure that the drug is at a therapeutic level. Too little tacrolimus may lead to organ rejection, while too much can increase the risk of side effects.
Side Effects:

Common side effects may include tremors, high blood pressure, kidney dysfunction, and an increased risk of infections.
Long-term use of immunosuppressive medications, including tacrolimus, may be associated with an increased risk of certain conditions, and close medical monitoring is necessary.
Caution:

TACRENOLIME 0.25 can interact with other medications, and its use requires careful consideration of potential drug interactions.
TACRENOLIME 0.25 is important for individuals taking tacrolimus to follow up regularly with their transplant team or healthcare provider.
Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
For further information please contact:
contact@sterispharma.com
order now:https://www.sterisonline.com/product/tacrenolime-0-25-133684